Literature DB >> 15891892

Epidermal growth factor and bombesin act synergistically to support intestinal adaptation in rats with massive small bowel resection.

Serdar H Iskit1, Halil Tugtepe, Suat H Ayyildiz, Esin Kotiloglu, Tolga E Dagli, Berrak C Yeğen.   

Abstract

Intestinal adaptation is the most important event in short bowel syndrome following a massive small bowel resection. Effects of various growth factors and their synergism have been well documented in intestinal adaptation. This study aimed to compare the effect of two different trophic agents, epidermal growth factor (EGF) and bombesin (BBS), on intestinal adaptation following massive intestinal resection. Sprague-Dawley male rats were assigned to one of four groups after a 75% small bowel resection. Either EGF (90 microg/kg), BBS (10 microg/kg), EGF+BBS, or bovine serum albumin (BSA) were injected subcutaneously three times a day. The animals were killed 10 days after the operation. Weight loss and morphologic parameters such as mucosal thickness, villus height, crypt depth, villus-to-crypt ratio, and muscularis propria height were measured. In the EGF+BBS group, mucosal thickness was found to be significantly increased compared with the other study groups (p<0.05). Similarly, villus height was significantly increased only in the EGF+BBS group (p<0.05). In the BBS group, both villus height and mucosal thickness showed a slight increase, but the values were not statistically significant compared with the vehicle-treated group. There were no significant differences in any of the remaining parameters between the groups. The results of this study indicate that the gut hormones EGF and BBS act synergistically in facilitating the adaptive response of the remnant ileum to massive intestinal resection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891892     DOI: 10.1007/s00383-005-1430-9

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  38 in total

1.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

2.  Effects of bombesin on mucosal ion transport in the mouse isolated jejunum.

Authors:  P J Rivière; R J Sheldon; M E Malarchik; T F Burks; F Porreca
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

3.  Bombesin prevents gastric injury in the rat: role of gastrin.

Authors:  D W Mercer; J M Cross; L Chang; L M Lichtenberger
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

Review 4.  Bombesin-like peptides: candidates as diagnostic and therapeutic tools.

Authors:  B C Yeğen
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

5.  Induction of transforming growth factor-alpha in activated human alveolar macrophages.

Authors:  D K Madtes; E W Raines; K S Sakariassen; R K Assoian; M B Sporn; G I Bell; R Ross
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

6.  Growth-factor enhancement of compromised gut function following massive small-bowel resection.

Authors:  M Z Schwartz; Y Kato; D Yu; J R Lukish
Journal:  Pediatr Surg Int       Date:  2000       Impact factor: 1.827

Review 7.  Short-bowel syndrome in children and adults.

Authors:  J A Vanderhoof; A N Langnas
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

8.  A comparison of the effect of growth factors on intestinal function and structure in short bowel syndrome.

Authors:  J Lukish; M Z Schwartz; J M Rushin; G P Riordan
Journal:  J Pediatr Surg       Date:  1997-11       Impact factor: 2.545

9.  Effect of epidermal growth factor, transforming growth factor alpha and nerve growth factor on gastric mucosal integrity and microcirculation in the rat.

Authors:  B L Tepperman; B D Soper
Journal:  Regul Pept       Date:  1994-02-03

10.  Bombesin stimulates mucosal growth in jejunal and ileal Thiry-Vella fistulas.

Authors:  K U Chu; S Higashide; B M Evers; J Ishizuka; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

View more
  4 in total

1.  Kampo medicine "Dai-kenchu-to" prevents CPT-11-induced small-intestinal injury in rats.

Authors:  Motoya Chikakiyo; Mitsuo Shimada; Toshihiro Nakao; Jun Higashijima; Kozo Yoshikawa; Masanori Nishioka; Takashi Iwata; Nobuhiro Kurita
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

Review 2.  Growth factors: possible roles for clinical management of the short bowel syndrome.

Authors:  Mark E McMellen; Derek Wakeman; Shannon W Longshore; Lucas A McDuffie; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2010-02       Impact factor: 2.754

3.  Medical and surgical management of the pediatric patient with intestinal failure.

Authors:  Frances R Malone; Simon P Horslen
Journal:  Curr Treat Options Gastroenterol       Date:  2007-10

4.  Kampo medicine "Dai-kenchu-to" prevents bacterial translocation in rats.

Authors:  Kozo Yoshikawa; Nobuhiro Kurita; Jun Higashijima; Tomohiko Miyatani; Hidenori Miyamoto; Masanori Nishioka; Mitsuo Shimada
Journal:  Dig Dis Sci       Date:  2008-04-30       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.